Bombay HC: Railway Employee With Valid Privilege Pass is Bona Fide Passenger Despite Missing Entries || Delhi High Court: Mere Pleadings Made To Prosecute or Defend a Case Do Not Amount To Defamation || Delhi High Court: Asking an Accused To Cross-Examine a Witness Without Legal Aid Vitiates The Trial || Delhi High Court: Recruitment Notice Error Creates No Appointment Right Without Vacancy || Supreme Court: Subordinate Legislation Takes Effect Only From its Publication in The Official Gazette || Supreme Court: DDA Must Adopt a Litigation Policy To Screen Cases and Avoid Unnecessary Filings || Authorities Holding Public Auctions Must Disclose All Known Encumbrances and Related Litigation || SC: Compensatory Allowances Must Be Included While Computing Overtime Wages U/S 59 of Factories Act || SC: NGT Has No Jurisdiction to Decide Disputes Relating to Building Plan Violations || SC: Evidence is Often Fabricated Using AI And False Allegations are Rampant in Matrimonial Cases

Drugs and Cosmetics (Amendment) Bill, 2015 - (30 Nov 2015)

Miscellaneous

The Drugs and Cosmetics (Amendment) Bill, 2015, set to be introduced in the Parliament’s Winter Session, 2015, proposes much needed updates to the Drugs and Cosmetics Act, 1940. The Bill, 2015 broadens the scope of the government’s powers and introduces checks and balances in the manufacture, import, distribution and sale of drugs and cosmetics in India. Clinical trials are set to be overseen by the Ethics Committee, constituted under the Bill. The Committee will also have powers to audit clinical trials and make site visits to ensure safety and well being of participants. Greater regulation and oversight, stricter punishments and vigilance outline the proactive stance the Bill proposes for the government.

Tags : DRUG AND COSMETICS BILL 2015 ETHICS COMMITTEE

Share :